| 1 |
1653497 |
Human cytomegalovirus strain Towne pp28 gene: sequence comparison to pp28 of HCMV AD169 and stable expression in Chinese hamster ovary cells |
Mutation
|
| 2 |
2159553 |
Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne |
Mutation
|
| 3 |
7559530 |
Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates |
Mutation
|
| 4 |
7738144 |
Value of a new rapid non-radioactive sequencing method for analysis of the cytomegalovirus UL97 gene in ganciclovir-resistant strains |
Mutation
|
| 5 |
8207815 |
Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir |
Mutation
|
| 6 |
8381637 |
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives |
Mutation
|
| 7 |
8892927 |
Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding |
Mutation
|
| 8 |
9260696 |
Humoral immune response to functional regions of human cytomegalovirus glycoprotein B |
Mutation
|
| 9 |
9420278 |
Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product |
Mutation
|
| 10 |
9558326 |
Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease |
Mutation
|
| 11 |
9573236 |
Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56 |
Mutation
|
| 12 |
9621055 |
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments |
Mutation
|
| 13 |
9658112 |
Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation state of Ser900 |
Mutation
|
| 14 |
9721246 |
A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture |
Mutation
|
| 15 |
9864050 |
Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant |
Mutation
|
| 16 |
11602710 |
Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression |
Mutation
|
| 17 |
11861863 |
Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication |
Mutation
|
| 18 |
11861864 |
SUMO-1 modification of human cytomegalovirus IE1/IE72 |
Mutation
|
| 19 |
12163586 |
Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions |
Mutation
|
| 20 |
12525621 |
Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents |
Mutation
|
| 21 |
12637079 |
Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase |
Mutation
|
| 22 |
12663783 |
Strain variations in single amino acids of the 86-kilodalton human cytomegalovirus major immediate-early protein (IE2) affect its functional and biochemical properties: implications of dynamic protein conformation |
Mutation
|
| 23 |
14557635 |
Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27 |
Mutation
|
| 24 |
14694102 |
Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides |
Mutation
|
| 25 |
15194788 |
Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir |
Mutation
|
| 26 |
15767408 |
Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B |
Mutation
|
| 27 |
15980340 |
Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene |
Mutation
|
| 28 |
16207954 |
Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir |
Mutation
|
| 29 |
16304146 |
New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure |
Mutation
|
| 30 |
16571804 |
Inhibition of cellular DNA synthesis by the human cytomegalovirus IE86 protein is necessary for efficient virus replication |
Mutation
|
| 31 |
16897654 |
Characterization of human cytomegalovirus (HCMV) UL97 mutations found in a valganciclovir/oral ganciclovir prophylactic trial by use of a bacterial artificial chromosome containing the HCMV genome |
Mutation
|
| 32 |
17079329 |
The amino-conserved domain of human cytomegalovirus UL80a proteins is required for key interactions during early stages of capsid formation and virus production |
Mutation
|
| 33 |
17197042 |
Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet |
Mutation
|
| 34 |
17376893 |
The autoregulatory and transactivating functions of the human cytomegalovirus IE86 protein use independent mechanisms for promoter binding |
Mutation
|
| 35 |
17942550 |
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant |
Mutation
|
| 36 |
18385241 |
Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus |
Mutation
|
| 37 |
18423509 |
Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein |
Mutation
|
| 38 |
18502683 |
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus |
Mutation
|
| 39 |
19369477 |
Biologic and immunologic effects of knockout of human cytomegalovirus pp65 nuclear localization signal |
Mutation
|
| 40 |
19546362 |
Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness |
Mutation
|
| 41 |
19570866 |
The flexible loop of the human cytomegalovirus DNA polymerase processivity factor ppUL44 is required for efficient DNA binding and replication in cells |
Mutation
|
| 42 |
20385869 |
Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance |
Mutation
|
| 43 |
20732421 |
Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia |
Mutation
|
| 44 |
20843736 |
Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene |
Mutation
|
| 45 |
20876378 |
Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase |
Mutation
|
| 46 |
21248036 |
Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment |
Mutation
|
| 47 |
21295516 |
Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy |
Mutation
|
| 48 |
21429239 |
The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein |
Mutation
|
| 49 |
21709106 |
Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet |
Mutation
|
| 50 |
21788463 |
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase |
Mutation
|
| 51 |
21865379 |
Mutation of glutamine to arginine at position 548 of IE2 86 in human cytomegalovirus leads to decreased expression of IE2 40, IE2 60, UL83, and UL84 and increased transcription of US8-9 and US29-32 |
Mutation
|
| 52 |
21900421 |
Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98 |
Mutation
|
| 53 |
21968367 |
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure |
Mutation
|
| 54 |
22552942 |
Human cytomegalovirus UL97 kinase alters the accumulation of CDK1 |
Mutation
|
| 55 |
22589554 |
Specific residues of a conserved domain in the N terminus of the human cytomegalovirus pUL50 protein determine its intranuclear interaction with pUL53 |
Mutation
|
| 56 |
23650158 |
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus |
Mutation
|
| 57 |
23650173 |
Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance |
Mutation
|
| 58 |
24501413 |
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction |
Mutation
|
| 59 |
25348532 |
Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89 |
Mutation
|
| 60 |
26259791 |
Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance |
Mutation
|
| 61 |
26559840 |
Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses |
Mutation
|
| 62 |
27044553 |
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance |
Mutation
|
| 63 |
27940027 |
Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene |
Mutation
|
| 64 |
28446569 |
Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591 to 603 of the Cytomegalovirus UL97 Kinase Gene |
Mutation
|
| 65 |
28807919 |
Drug Susceptibility and Replicative Capacity of Multidrug-Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes |
Mutation
|
| 66 |
28827420 |
Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds |
Mutation
|
| 67 |
28878758 |
Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes |
Mutation
|
| 68 |
29107686 |
A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance |
Mutation
|
| 69 |
29649495 |
A Guinea pig cytomegalovirus resistant to the DNA maturation inhibitor BDCRB |
Mutation
|
| 70 |
29914965 |
New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir |
Mutation
|
| 71 |
30258013 |
Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0 |
Mutation
|
| 72 |
31427511 |
Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability |
Mutation
|
| 73 |
31431555 |
Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34(+) Hematopoietic Progenitor Cells and Humanized NSG Mice |
Mutation
|
| 74 |
31941787 |
Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry |
Mutation
|
| 75 |
32015044 |
Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase |
Mutation
|
| 76 |
32321808 |
The Human Cytomegalovirus Transmembrane Protein pUL50 Induces Loss of VCP/p97 and Is Regulated by a Small Isoform of pUL50 |
Mutation
|
| 77 |
32690704 |
Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor |
Mutation
|
| 78 |
33588012 |
Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases |
Mutation
|
| 79 |
33875432 |
Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet |
Mutation
|
| 80 |
34082757 |
Genome sequences of human cytomegalovirus strain TB40/E variants propagated in fibroblasts and epithelial cells |
Mutation
|
| 81 |
34201364 |
Selection of Human Cytomegalovirus Mutants with Resistance against PDGFRalpha-Derived Entry Inhibitors |
Mutation
|
| 82 |
34550009 |
Characteristics of Immediate-Early 2 (IE2) and UL84 Proteins in UL84-Independent Strains of Human Cytomegalovirus (HCMV) |
Mutation
|
| 83 |
34560144 |
Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility |
Mutation
|
| 84 |
35185843 |
Analysis of Novel Drug-Resistant Human Cytomegalovirus DNA Polymerase Mutations Reveals the Role of a DNA-Binding Loop in Phosphonoformic Acid Resistance |
Mutation
|
| 85 |
35746751 |
Design of a US28 ORF Deletion Virus in a Temperature-Sensitive Cytomegalovirus Strain Fails to Promote Lytic Replication in Hematopoietic Cells |
Mutation
|
| 86 |
37113003 |
The RL13 Temperance Factor Represses Replication of the Highly Cell Culture-Adapted Towne Strain of Human Cytomegalovirus |
Mutation
|
| 87 |
37976321 |
A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex |
Mutation
|
| 88 |
38163624 |
Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants |
Mutation
|
| 89 |
39315800 |
Growth defect of domain III glycoprotein B mutants of human cytomegalovirus reverted by compensatory mutations co-localizing in post-fusion conformation |
Mutation
|
| 90 |
39655954 |
Third intracellular loop of HCMV US28 is necessary for signaling and viral reactivation |
Mutation
|
| 91 |
38805802 |
Structure-guided mutagenesis targeting interactions between pp150 tegument protein and small capsid protein identify five lethal and two live-attenuated HCMV mutants |
Mutation
|